- Home
- CNTX vs VATE Comparison
CNTX vs VATE Comparison
Compare CNTX & VATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTX
- VATE
- Stock Information
- Founded
- CNTX 2015
- VATE 1994
- Country
- CNTX United States
- VATE United States
- Employees
- CNTX N/A
- VATE N/A
- Industry
- CNTX Biotechnology: Pharmaceutical Preparations
- VATE Metal Fabrications
- Sector
- CNTX Health Care
- VATE Industrials
- Exchange
- CNTX Nasdaq
- VATE Nasdaq
- Market Cap
- CNTX 75.6M
- VATE 65.1M
- IPO Year
- CNTX 2021
- VATE 1996
- Fundamental
- Price
- CNTX $0.82
- VATE $5.46
- Analyst Decision
- CNTX Strong Buy
- VATE
- Analyst Count
- CNTX 5
- VATE 0
- Target Price
- CNTX $5.25
- VATE N/A
- AVG Volume (30 Days)
- CNTX 162.2K
- VATE 22.6K
- Earning Date
- CNTX 11-05-2025
- VATE 11-05-2025
- Dividend Yield
- CNTX N/A
- VATE N/A
- EPS Growth
- CNTX N/A
- VATE N/A
- EPS
- CNTX N/A
- VATE N/A
- Revenue
- CNTX N/A
- VATE $995,000,000.00
- Revenue This Year
- CNTX N/A
- VATE N/A
- Revenue Next Year
- CNTX N/A
- VATE N/A
- P/E Ratio
- CNTX N/A
- VATE N/A
- Revenue Growth
- CNTX N/A
- VATE N/A
- 52 Week Low
- CNTX $0.49
- VATE $3.25
- 52 Week High
- CNTX $2.59
- VATE $13.79
- Technical
- Relative Strength Index (RSI)
- CNTX 52.03
- VATE 53.79
- Support Level
- CNTX $0.81
- VATE $5.10
- Resistance Level
- CNTX $0.94
- VATE $5.72
- Average True Range (ATR)
- CNTX 0.05
- VATE 0.40
- MACD
- CNTX -0.01
- VATE 0.09
- Stochastic Oscillator
- CNTX 10.36
- VATE 79.69
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
About VATE INNOVATE Corp.
Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting station across the United States.